ONWARD Medical and Partners Receives Grant from Christopher & Dana Reeve Foundation to Further Study Brain-Computer Interface System Page 1

The grant will enable ONWARD Medical, CEA-Clinatec and .NeuroRestore to evaluate the use of the ONWARD ARC-BCI system to restore thought-controlled movements of the hands and arms after spinal cord injury (SCI)

EINDHOVEN, Netherlands, Sept. 3, 2024 (GLOBE NEWSWIRE) — ONWARD Medical NV (Euronext: ONWD), the medical technology company developing innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced a grant from the Christopher & Dana Reeve Foundation to support the expansion of an ongoing clinical feasibility study investigating the use of a brain-computer interface (BCI) to restore thought-controlled use of the hands and arms after SCI.